메뉴 건너뛰기




Volumn 32, Issue 1, 2011, Pages 12-16

Gastric cancer in India

Author keywords

Clinical; epidemiological studies; gastric cancer; India

Indexed keywords

CANCER INCIDENCE; CANCER PATIENT; DEVELOPED COUNTRY; HUMAN; INDIA; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH CANCER;

EID: 79959386441     PISSN: 09715851     EISSN: 09752129     Source Type: Journal    
DOI: 10.4103/0971-5851.81884     Document Type: Review
Times cited : (38)

References (33)
  • 1
    • 0032009834 scopus 로고    scopus 로고
    • Estimate of cancer incidence in India in 1991
    • V Rao DN, Ganesh B. Estimate of cancer incidence in India in 1991. Indian J Cancer 1998;35:10-8. (Pubitemid 128529218)
    • (1998) Indian Journal of Cancer , vol.35 , Issue.1 , pp. 10-18
    • Rao, D.N.1    Ganesh, B.2
  • 3
    • 0038526411 scopus 로고    scopus 로고
    • Gastric cancer in India
    • DOI 10.1007/s101200200042
    • Pavithran K, Doval DC, Pandey KK. Gastric cancer in India. Gastric Cancer 2002;5:240-3. (Pubitemid 36605889)
    • (2002) Gastric Cancer , vol.5 , Issue.4 , pp. 240-243
    • Pavithran, K.1    Doval, D.C.2    Pandey, K.K.3
  • 4
    • 58349099102 scopus 로고    scopus 로고
    • Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India
    • Yeole BB. Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India. Asian Pac J Cancer Prev 2008;9:97-100.
    • (2008) Asian Pac J Cancer Prev , vol.9 , pp. 97-100
    • Yeole, B.B.1
  • 5
    • 40449084183 scopus 로고    scopus 로고
    • Life time risk for development of ten major cancers in India and its trends over the years 1982 to 2000
    • Satyanarayana L, Asthana S. Life time risk for development of ten major cancers in India and its trends over the years 1982 to 2000. Indian J Med Sci 2008;62:35-44. (Pubitemid 351355045)
    • (2008) Indian Journal of Medical Sciences , vol.62 , Issue.2 , pp. 35-44
    • Satyanarayana, L.1    Asthana, S.2
  • 7
    • 0014117318 scopus 로고
    • Geographical distribution of gastrointestinal cancers in India with special reference to causation
    • Malhotra SL. Geographical distribution of gastrointestinal cancers in India with special reference to causation. Gut 1967;8:361-72.
    • (1967) Gut , vol.8 , pp. 361-372
    • Malhotra, S.L.1
  • 11
    • 9744237422 scopus 로고    scopus 로고
    • High prevalence of stomach cancer among the people of Mizoram, India
    • Phukan RK, Zomawia E, Hazarika NC, Baruah D, Mahanta J. High prevalence of stomach cancer among the people of Mizoram, India. Curr Sci 2004;87:285-6. (Pubitemid 39583990)
    • (2004) Current Science , vol.87 , Issue.3 , pp. 285-286
    • Phukan, R.K.1    Zomawia, E.2    Hazarlka, N.C.3    Baruah, D.4    Mahanta, J.5
  • 15
    • 34447103788 scopus 로고    scopus 로고
    • Diet, H pylori infection and gastric cancer: Evidence and controversies
    • Rocco A, Nardone G. Diet, H pylori infection and gastric cancer: Evidence and controversies. World J Gastroenterol 2007;13:2901-12. (Pubitemid 47028879)
    • (2007) World Journal of Gastroenterology , vol.13 , Issue.21 , pp. 2901-2912
    • Rocco, A.1    Nardone, G.2
  • 16
    • 33645504595 scopus 로고    scopus 로고
    • Causal role of Helicobacter pylori infection in gastric cancer: An Asian enigma
    • Singh K, Ghoshal UC. Causal role of Helicobacter pylori infection in gastric cancer: An Asian enigma. World J Gastroenterol 2006;12:1346-51.
    • (2006) World J Gastroenterol , vol.12 , pp. 1346-1351
    • Singh, K.1    Ghoshal, U.C.2
  • 17
    • 77749252149 scopus 로고    scopus 로고
    • Surgery for gastric cancer: An evidence-based perspective
    • D'souza MA, Singh K, Shrikhande SV. Surgery for gastric cancer: An evidence-based perspective. J Cancer Res Ther 2009;5:225-31.
    • (2009) J Cancer Res Ther , vol.5 , pp. 225-231
    • D'Souza, M.A.1    Singh, K.2    Shrikhande, S.V.3
  • 18
    • 48249141410 scopus 로고    scopus 로고
    • D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer
    • Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008;359:453-62.
    • (2008) N Engl J Med , vol.359 , pp. 453-462
    • Sasako, M.1    Sano, T.2    Yamamoto, S.3    Kurokawa, Y.4    Nashimoto, A.5    Kurita, A.6
  • 19
    • 4344569457 scopus 로고    scopus 로고
    • Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group study 9501
    • DOI 10.1200/JCO.2004.10.184
    • Sano T, Sasako M, Yamamoto S, Nashimoto A, Kurita A, Hiratsuka M, et al. Gastric cancer surgery: Morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004;22:2767-73. (Pubitemid 41079893)
    • (2004) Journal of Clinical Oncology , vol.22 , Issue.14 , pp. 2767-2773
    • Sano, T.1    Sasako, M.2    Yamamoto, S.3    Nashimoto, A.4    Kurita, A.5    Hiratsuka, M.6    Tsujinaka, T.7    Kinoshita, T.8    Arai, K.9    Yamamura, Y.10    Okajima, K.11
  • 24
    • 33748689963 scopus 로고    scopus 로고
    • D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials
    • DOI 10.1159/000094537
    • Shrikhande SV, Shukla PJ, Qureshi S, Siddachari R, Upasani V, Ramadwar M, et al. D2 lymphadenectomy for gastric cancer in Tata Memorial Hospital: Indian data can now be incorporated in future international trials. Dig Surg 2006;23:192-7. (Pubitemid 44394175)
    • (2006) Digestive Surgery , vol.23 , Issue.3 , pp. 192-197
    • Shrikhande, S.V.1    Shukla, P.J.2    Qureshi, S.3    Siddachari, R.4    Upasani, V.5    Ramadwar, M.6    Kakade, A.C.7    Hawaldar, R.8
  • 27
    • 31544445256 scopus 로고    scopus 로고
    • Evolving chemotherapy for advanced gastric cancer
    • DOI 10.1634/theoncologist.10-90003-49
    • Ajani JA. Evolving chemotherapy for advanced gastric cancer. Oncologist 2005;10:49-58. (Pubitemid 43153809)
    • (2005) Oncologist , vol.10 , Issue.SUPPL. 3 , pp. 49-58
    • Ajani, J.A.1
  • 28
    • 33745151412 scopus 로고    scopus 로고
    • Phase II study of cisplatin, etoposide and paclitaxel in locally advanced or metastatic adenocarcinoma of gastric/gastroesophageal junction
    • Sharma A, Raina V, Lokeshwar N, Deo SV, Shukla NK, Mohanti BK. Phase II study of cisplatin, etoposide and paclitaxel in locally advanced or metastatic adenocarcinoma of gastric/gastroesophageal junction. Indian J Cancer 2006;43:16-9. (Pubitemid 43900537)
    • (2006) Indian Journal of Cancer , vol.43 , Issue.1 , pp. 16-19
    • Sharma, A.1    Raina, V.2    Lokeshwar, N.3    Deo, S.V.S.4    Shukla, N.K.5    Mohanti, B.K.6
  • 30
    • 60849118127 scopus 로고    scopus 로고
    • Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction
    • Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol 2009;27:851-6.
    • (2009) J Clin Oncol , vol.27 , pp. 851-856
    • Stahl, M.1    Walz, M.K.2    Stuschke, M.3    Lehmann, N.4    Meyer, H.J.5    Riera-Knorrenschild, J.6
  • 32
    • 0035818048 scopus 로고    scopus 로고
    • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
    • Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.
    • (2001) N Engl J Med , vol.345 , pp. 725-730
    • MacDonald, J.S.1    Smalley, S.R.2    Benedetti, J.3    Hundahl, S.A.4    Estes, N.C.5    Stemmermann, G.N.6
  • 33
    • 77956262693 scopus 로고    scopus 로고
    • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomized controlled trial
    • Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomized controlled trial. Lancet 2010;376:687-97.
    • (2010) Lancet , vol.376 , pp. 687-697
    • Bang, Y.J.1    Van Cutsem, E.2    Feyereislova, A.3    Chung, H.C.4    Shen, L.5    Sawaki, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.